Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,772 public trials 697 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies

NCT06220097

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Refractory, Burkitt Lymphoma, +16 more
Locations: Union Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Active, Not Recruiting

Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma

NCT03843294

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Utah University School of Medicine/Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Active, Not Recruiting

A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma

NCT06742879

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: the First Affiliated Hospital of zhengzhou University Zhengzhou, Henan, China

View Trial Details

Active, Not Recruiting

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

NCT03995147

Conditions: B Cell Lymphoma, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

NCT06601504

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Guangxi Medical University Cancer Hospital Nanning, Guangxi, China

Wuhan Union Hospital of China Wuhan, Hebei, China

View all 16 locations

View Trial Details

Active, Not Recruiting

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL

NCT04668690

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

NCT06552572

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)

NCT04460248

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Shanghai Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma

NCT03952078

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Stanford University Palo Alto, California, United States

University of Michigan Ann Arbor, Michigan, United States

Washington University St Louis, Missouri, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View all 22 locations

View Trial Details

Active, Not Recruiting

Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy

NCT04904536

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +24 more
Locations: The George Institute for Global Health Sydney, New South Wales, Australia

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions